Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Goodwill (2016 - 2017)

Lisata Therapeutics filings provide 8 years of Goodwill readings, the most recent being $7.0 million for Q1 2017.

  • For the quarter ending Q1 2017, Goodwill changed 0.0% year-over-year to $7.0 million, compared with a TTM value of $7.0 million through Mar 2017, changed 0.0%, and an annual FY2016 reading of $7.0 million, changed 0.0% over the prior year.
  • Goodwill hit $7.0 million in Q1 2017 for Lisata Therapeutics, roughly flat from $7.0 million in the prior quarter.
  • The five-year high for Goodwill was $26.1 million in Q2 2014, with the low at $7.0 million in Q2 2016.
  • Median Goodwill over the past 5 years was $11.1 million (2013), compared with a mean of $14.7 million.
  • The sharpest move saw Goodwill surged 134.58% in 2014, then tumbled 72.23% in 2016.
  • Year by year, Goodwill stood at $11.1 million in 2013, then surged by 126.75% to $25.2 million in 2014, then plummeted by 72.18% to $7.0 million in 2015, then changed by 0.0% to $7.0 million in 2016, then changed by 0.0% to $7.0 million in 2017.
  • According to Business Quant data, Goodwill over the past three periods came in at $7.0 million, $7.0 million, and $7.0 million for Q1 2017, Q4 2016, and Q3 2016 respectively.